The UCI Chao Family Comprehensive Cancer Center (CFCCC), led by Associate Vice Chancellor and Director Richard A. Van Etten, MD, PhD, is the only National Cancer Institute (NCI)-designated comprehensive cancer center in Orange County. NCI cancer centers are national leaders in cancer research, education and treatment, and centers designated as "comprehensive" are at the forefront, signifying that it has met rigorous criteria aimed at providing world-class patient care and innovative research.

The UCI Institute for Clinical and Translational Science (ICTS), led by Associate Vice Chancellor and Director Dan Cooper, MD, is funded by the National Institutes of Health (NIH) under the Clinical and Translational Sciences Award (CTSA) program. Currently, there are more than 50 medical research institutions throughout the United States that receive CTSA program funding. The ICTS functions as a local centerpiece for the national program, and is dedicated to advancing scientific discovery and medical breakthroughs. Collectively, our goal is simple: to accelerate these discoveries from the lab and translate them into life-altering medical care.

The UCI Precision Health through Artificial Intelligence Initiative is led by Co-Directors Leslie M. Thompson, Ph.D., Peter D. Chang, M.D., Daniel S. Chow, M.D., and Suzanne Sandmeyer, Ph.D. Vastly improved health and longer lifespans also bring chronic disorders arising from cumulative genetic, environmental and metabolic factors. Simultaneously, the increasing sophistication of medical diagnostics yields an exponential growth in the density and complexity of aggregated healthcare data. Together, these factors provide an unprecedented opportunity to study differences in disease among individuals and provide tailored patient care. The mission of the UCI Precision Health through Artificial Intelligence Initiative is to leverage machine learning technology to transform population-through molecular-level data into personalized health solutions, and make these tools available to providers and patients around the world.

The UCI Sue and Bill Gross Stem Cell Research Center, led by Director Aileen J. Anderson, Ph.D., is a dynamic center encompassing a diverse array of interdisciplinary investigators that span the Schools of Medicine, Biological Sciences, Pharmacy & Pharmaceutical Sciences, Engineering, Arts and Law. Our state-of-the-art, LEED Platinum certified research and clinical building houses 23 of our 50 center faculty. Center faculty have obtained more than $200 million dollars in grant and foundation funds (including over $125 million dollars from the California Institute for Regenerative Medicine). Our research programs include an NIH-sponsored T32 training grant, state-of-the-art shared equipment and research services programs, community lecture series, annual stem cell science symposium and seminar series.